Genos is a leading research organization specialising in glycomics, DNA analysis, and epigenetics. It performs over 50,000 glycan analyses annually and has contributed to more than 300 publications. With strong expertise in biomarker research and advanced technologies, Genos supports innovation in clinical research, biotechnology, and personalised medicine.
In the SynHealth, Genos coordinates the project, leads glycomics research and biomarker validation, and conducts valorisation studies to define clinical applications. It develops regulatory roadmaps for CE-IVDR, builds clinical networks, and supports AI-based tools and ERDF proposals to translate results into diagnostics and healthcare solutions.
